Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Western Blot Products
  4. Western Blot Substrates and Substrate Kits
  5. NB526286

Novus Biologicals™ UltraScence Pico Plus Western Substrate
SDP

Catalog No. NB526286 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB526286 100 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB526286 Supplier Novus Biologicals™ Supplier No. NBP333176
Only null left
Add to Cart
Add to Cart

Description

Luminol-based enhanced chemiluminescent substrate

The UltraScence Pico Plus Western Substrate, as a luminol-based enhanced chemiluminescent substrate, is sensitive and compatible with conducting immunoblots with horseradish peroxidase (HRP) - conjugated secondary antibodies. The low picogram or high femtogram detection of antigen is enabled by UltraScence Pico Plus Western Substrate's excellent sensitivity and long signal duration. Further, its long chemiluminescent signal duration makes both digital and film-based imaging possible without any loss of the signal. Appropriate primary and secondary antibody dilutions are suggested for attaining optimal signal intensity and duration.

Specifications

For Use With (Application) Western Blot
Quantity 100 mL
Content And Storage Store at 4°C. Do not freeze.
Target UltraScence Pico Plus Western Substrate
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.